Pricing
Login
Home
Charts
Search
Watchlist
Products

Alkem Laboratories Ltd

₹5,185.00+0.78%20 Nov 2026
Reports
Pharma Formulations

Alkem Laboratories Ltd

₹5,185.00
+0.78%
20 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹61,994Cr
Close
Close Price
₹5,185.00
Industry
Industry
Pharma Formulations
PE
Price To Earnings
29.98
PS
Price To Sales
3.97
Revenue
Revenue
₹15,632Cr
Rev Gr TTM
Revenue Growth TTM
12.54%
PAT Gr TTM
PAT Growth TTM
-13.16%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
3,3242,9363,0323,4153,3743,1443,3714,0013,7373,6033,7404,552
Growth YoY
Revenue Growth YoY%
9.31.12.2-0.71.57.111.217.210.714.610.913.8
Expenses
ExpensesCr
2,6162,5342,4232,6622,6152,7522,6323,0802,9093,0862,9743,527
Operating Profit
Operating ProfitCr
7084026097537593917399218285177661,025
OPM
OPM%
21.313.720.122.122.512.421.923.022.214.420.522.5
Other Income
Other IncomeCr
4276120134931461491049065153169
Interest Expense
Interest ExpenseCr
252729283628303542544758
Depreciation
DepreciationCr
7083807985112889495106100137
PBT
PBTCr
6553676197807313967718967814237721,000
Tax
TaxCr
516369789073103116128171251332
PAT
PATCr
604304550702641323668780654252521668
Growth YoY
PAT Growth YoY%
31.4349.991.214.26.06.121.511.12.0-22.1-22.0-14.3
NPM
NPM%
18.210.418.120.619.010.319.819.517.57.013.914.7
EPS
EPS₹
49.824.645.657.652.325.655.664.053.219.843.556.5
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
3,3242,9363,0323,4153,3743,1443,3714,0013,7373,6033,7404,552
Growth YoY
Revenue Growth YoY%
9.31.12.2-0.71.57.111.217.210.714.610.913.8
Expenses
ExpensesCr
2,6162,5342,4232,6622,6152,7522,6323,0802,9093,0862,9743,527
Operating Profit
Operating ProfitCr
7084026097537593917399218285177661,025
OPM
OPM%
21.313.720.122.122.512.421.923.022.214.420.522.5
Other Income
Other IncomeCr
4276120134931461491049065153169
Interest Expense
Interest ExpenseCr
252729283628303542544758
Depreciation
DepreciationCr
7083807985112889495106100137
PBT
PBTCr
6553676197807313967718967814237721,000
Tax
TaxCr
516369789073103116128171251332
PAT
PATCr
604304550702641323668780654252521668
Growth YoY
PAT Growth YoY%
31.4349.991.214.26.06.121.511.12.0-22.1-22.0-14.3
NPM
NPM%
18.210.418.120.619.010.319.819.517.57.013.914.7
EPS
EPS₹
49.824.645.657.652.325.655.664.053.219.843.556.5

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
4,9255,6886,4017,3578,3448,86510,63411,59912,66812,96514,71215,632
Growth
Revenue Growth%
31.615.512.614.913.46.220.09.19.22.313.512.5
Expenses
ExpensesCr
4,0724,6895,3926,2426,8716,9238,5819,99010,42210,45211,70712,496
Operating Profit
Operating ProfitCr
8539991,0091,1151,4731,9422,0531,6092,2452,5123,0053,137
OPM
OPM%
17.317.615.815.217.721.919.313.917.719.420.420.1
Other Income
Other IncomeCr
24011211588104233148113189494409477
Interest Expense
Interest ExpenseCr
71455555655952107112122161200
Depreciation
DepreciationCr
93101143193253275304310299357382438
PBT
PBTCr
9289659269551,2601,8421,8441,3052,0232,5272,8712,976
Tax
TaxCr
17660288181110224164298212311518881
PAT
PATCr
7529056387741,1491,6181,6801,0071,8112,2162,3532,094
Growth
PAT Growth%
92.120.3-29.421.248.640.83.9-40.179.922.36.2-13.2
NPM
NPM%
15.315.910.010.513.818.315.88.714.317.116.013.4
EPS
EPS₹
62.074.652.863.694.3132.6137.682.3150.2181.1192.5172.9
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
4,9255,6886,4017,3578,3448,86510,63411,59912,66812,96514,71215,632
Growth
Revenue Growth%
31.615.512.614.913.46.220.09.19.22.313.512.5
Expenses
ExpensesCr
4,0724,6895,3926,2426,8716,9238,5819,99010,42210,45211,70712,496
Operating Profit
Operating ProfitCr
8539991,0091,1151,4731,9422,0531,6092,2452,5123,0053,137
OPM
OPM%
17.317.615.815.217.721.919.313.917.719.420.420.1
Other Income
Other IncomeCr
24011211588104233148113189494409477
Interest Expense
Interest ExpenseCr
71455555655952107112122161200
Depreciation
DepreciationCr
93101143193253275304310299357382438
PBT
PBTCr
9289659269551,2601,8421,8441,3052,0232,5272,8712,976
Tax
TaxCr
17660288181110224164298212311518881
PAT
PATCr
7529056387741,1491,6181,6801,0071,8112,2162,3532,094
Growth
PAT Growth%
92.120.3-29.421.248.640.83.9-40.179.922.36.2-13.2
NPM
NPM%
15.315.910.010.513.818.315.88.714.317.116.013.4
EPS
EPS₹
62.074.652.863.694.3132.6137.682.3150.2181.1192.5172.9
Sales CAGR
1 Year13%
3 Years8%
5 Years11%
TTM13%
EBITDA CAGR
1 Year20%
3 Years23%
5 Years9%
TTM12%
PAT CAGR
1 Year6%
3 Years33%
5 Years8%
TTM-13%
Avg. ROCE
1 Year19%
3 Years19%
5 Years17%
TTM19%
CFO / EBITDA
1 Year65%
3 Years75%
5 Years75%
TTM-

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
242424242424242424242424
Reserves
ReservesCr
3,6684,4444,8405,4156,1377,3538,6149,02110,28811,96113,79614,841
Current Liabilities
Current LiabilitiesCr
1,5381,6902,3832,1903,2453,6044,8053,7073,9953,9614,7834,709
Non Current Liabilities
Non Current LiabilitiesCr
2102952974463923574176158661,2971,7412,662
Total Liabilities
Total LiabilitiesCr
5,5356,5687,6668,2089,94611,51914,06913,75715,57517,69120,87323,060
Current Assets
Current AssetsCr
2,7692,9174,0134,2165,5066,9298,4348,73010,41210,81112,21112,982
Non Current Assets
Non Current AssetsCr
2,7663,6513,6523,9924,4404,5905,6355,0275,1636,8808,66210,078
Total Assets
Total AssetsCr
5,5356,5687,6668,2089,94611,51914,06913,75715,57517,69120,87323,060
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
242424242424242424242424
Reserves
ReservesCr
3,6684,4444,8405,4156,1377,3538,6149,02110,28811,96113,79614,841
Current Liabilities
Current LiabilitiesCr
1,5381,6902,3832,1903,2453,6044,8053,7073,9953,9614,7834,709
Non Current Liabilities
Non Current LiabilitiesCr
2102952974463923574176158661,2971,7412,662
Total Liabilities
Total LiabilitiesCr
5,5356,5687,6668,2089,94611,51914,06913,75715,57517,69120,87323,060
Current Assets
Current AssetsCr
2,7692,9174,0134,2165,5066,9298,4348,73010,41210,81112,21112,982
Non Current Assets
Non Current AssetsCr
2,7663,6513,6523,9924,4404,5905,6355,0275,1636,8808,66210,078
Total Assets
Total AssetsCr
5,5356,5687,6668,2089,94611,51914,06913,75715,57517,69120,87323,060

Cash Flow

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
7264712667775851,2651,1111,6831,9481,9131,963
Investing Cash Flow
Investing Cash FlowCr
202-286-357-314-741-999-1,435113-1,009-1,299-1,667
Financing Cash Flow
Financing Cash FlowCr
-927-13885-37979-272380-1,761-1,145-811-503
Net Cash Flow
Net Cash FlowCr
147-784-77-55535-205-197-208
Free Cash Flow
Free Cash FlowCr
472-163-4112502371,0807831,4531,7611,2781,476
CFO To PAT
CFO To PAT%
96.552.141.7100.550.978.266.1167.1107.586.383.4
CFO To EBITDA
CFO To EBITDA%
85.147.226.469.739.765.154.1104.586.876.165.3
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
7264712667775851,2651,1111,6831,9481,9131,963
Investing Cash Flow
Investing Cash FlowCr
202-286-357-314-741-999-1,435113-1,009-1,299-1,667
Financing Cash Flow
Financing Cash FlowCr
-927-13885-37979-272380-1,761-1,145-811-503
Net Cash Flow
Net Cash FlowCr
147-784-77-55535-205-197-208
Free Cash Flow
Free Cash FlowCr
472-163-4112502371,0807831,4531,7611,2781,476
CFO To PAT
CFO To PAT%
96.552.141.7100.550.978.266.1167.1107.586.383.4
CFO To EBITDA
CFO To EBITDA%
85.147.226.469.739.765.154.1104.586.876.165.3

Ratios

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
16,33926,38723,63820,94527,84533,14643,24840,62659,06858,34863,40961,994
Price To Earnings
Price To Earnings
22.030.137.527.524.720.926.341.332.926.927.530.0
Price To Sales
Price To Sales
3.34.63.72.93.33.74.13.54.74.54.34.0
Price To Book
Price To Book
4.45.94.93.94.54.55.04.55.74.94.64.2
EV To EBITDA
EV To EBITDA
18.926.723.719.019.216.921.124.526.223.121.220.3
Profitability Ratios
Profitability Ratios
GPM
GPM%
56.156.154.552.853.955.055.152.556.056.459.059.0
OPM
OPM%
17.317.615.815.217.721.919.313.917.719.420.420.1
NPM
NPM%
15.315.910.010.513.818.315.88.714.317.116.013.4
ROCE
ROCE%
23.419.717.115.917.121.016.813.518.219.819.119.0
ROE
ROE%
20.420.313.114.218.721.919.411.117.618.517.014.1
ROA
ROA%
13.613.88.39.411.614.011.97.311.612.511.39.1
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
16,33926,38723,63820,94527,84533,14643,24840,62659,06858,34863,40961,994
Price To Earnings
Price To Earnings
22.030.137.527.524.720.926.341.332.926.927.530.0
Price To Sales
Price To Sales
3.34.63.72.93.33.74.13.54.74.54.34.0
Price To Book
Price To Book
4.45.94.93.94.54.55.04.55.74.94.64.2
EV To EBITDA
EV To EBITDA
18.926.723.719.019.216.921.124.526.223.121.220.3
Profitability Ratios
Profitability Ratios
GPM
GPM%
56.156.154.552.853.955.055.152.556.056.459.059.0
OPM
OPM%
17.317.615.815.217.721.919.313.917.719.420.420.1
NPM
NPM%
15.315.910.010.513.818.315.88.714.317.116.013.4
ROCE
ROCE%
23.419.717.115.917.121.016.813.518.219.819.119.0
ROE
ROE%
20.420.313.114.218.721.919.411.117.618.517.014.1
ROA
ROA%
13.613.88.39.411.614.011.97.311.612.511.39.1
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Market CapitalizationMkt CapCr1,03,51092,09974,73361,99459,38654,98146,778
Close PriceClose₹1,799.002,014.002,648.005,185.00364.403,331.901,843.80
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE26.0917.2451.4929.98121.8744.4432.46
Price To SalesPS2.803.004.693.973.417.774.46
RevenueRevenueCr36,91330,74615,93715,63217,4157,07210,479
Revenue Growth TTMRev Gr TTM%13.5%24.2%-0.1%12.5%5.7%21.9%12.0%
PAT Growth TTMPAT Gr TTM%16.5%20.1%43.7%-13.2%-55.4%56.4%72.8%
Market CapitalizationMkt CapCr1,03,51092,09974,73361,99459,38654,98146,778
Close PriceClose₹1,799.002,014.002,648.005,185.00364.403,331.901,843.80
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE26.0917.2451.4929.98121.8744.4432.46
Price To SalesPS2.803.004.693.973.417.774.46
RevenueRevenueCr36,91330,74615,93715,63217,4157,07210,479
Revenue Growth TTMRev Gr TTM%13.5%24.2%-0.1%12.5%5.7%21.9%12.0%
PAT Growth TTMPAT Gr TTM%16.5%20.1%43.7%-13.2%-55.4%56.4%72.8%
Interviews